pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-412 |
Genomic Coordinates | chr14: 101065447 - 101065537 |
Synonyms | MIRN412, hsa-mir-412, MIR412 |
Description | Homo sapiens miR-412 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-412-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 54| ACUUCACCUGGUCCACUAGCCGU |76 | |||||||||||||||||||||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TMEM105 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | transmembrane protein 105 | ||||||||||||||||||||
Transcript | NM_178520 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TMEM105 | |||||||||||||||||||||
3'UTR of TMEM105 (miRNA target sites are highlighted) |
>TMEM105|NM_178520|3'UTR 1 CTGCCATCTCTTCCTCCTCATCGTGTTTTTCACCTCTTAAGTCAACTTTAGATTCTCGGACTCAGAGTTCTCTCCTGACG 81 GTGGCAGGGTCCTCAGATCACCGGTGCAGACAGGGCCAGACAGGGCCAATGTGGGGACCCACTCAGCCTGTGGCCTCTGC 161 AGGAGGGAGGTCGGAGGCCTCAGCAGCCACCCCGGCCACCTCCTGAAACAGTGAATGTCCTTCATTTTCAGCTGGCAAGC 241 TCTGATCTTACAACGAGGTATGGAACTGTTCAGAAAACTTTCAGCAGACGTTCGAGGGAAAACAGCTCAGCTTCCCATGC 321 CCCCCACCTCTGCCAGGAGCGACCCCATATCCCCCAAACAGAATTCTGGTAGCCCGGGACCACAGGGTCTTCCTGTGCCT 401 CCCCTGCCAGCTCTGCATGACTTTGTCACGTACTTGAGTGCTGGCTGAGATGATGCTACCGCTACCAAACAGGTGGGAGG 481 CCAGCCCCAGCCCCAGCCCCAGCCCCACCGGGGCCGGAGCTCCCGGTGAAGAAGCGTCTGCCTGGTTCGCAGGTGTCCAG 561 GACACACCAGTCGCCTGACTCCCGGTCAGGCAAACGCACACATCAAGTTCTTGCAAGCCAGGGCTCTGCTGGCATCTTCA 641 AGAGGAGGGAGGGTCCTGGCCCTGACCACAGGGCTCCCTTAACAGGAGGAGTTACAAACTCGGCTTCCTGGGGGGCATCG 721 TGGGGTGTGCTGCCTGCCAGGAGACCCCACTCCTGGTCACGGGGTTCCGTCCCACACAGTGGCAGGAGCCATGCATGATT 801 CTTGGCTGAAGAAGAACCCGCACAGCTATGTGGTCTGCCGCCCAGCAGGGAAGCCCCCACATCAGCCCTAAGGGAACTTC 881 CCAAAGCTCAGCAGGTGCCTCTTCCTGCCATCCGCTAGGTCTTCTCTTGGCCCCTCTCCCAAGCCTTGACCCATAGCTGA 961 CACTTCTAGAAAAGTCTTTACCGAGAAACGGACCGGCTGCATGGGTGGTGAGGAGGGCAGTTGCCCAGGGCCTGGCATCA 1041 GAGGGGCCTGTGGCTAAGGCTGTCCTGAAATTCTTAATCATTTTACCTCTGAACTTGCGGGTTTTTGTTGTTGTTTTTTG 1121 AGGCAGAGTCTTGCTCTGTCACCCAGGCTGGAGTGCAGTGGTGCGATCTTGGCTTACTGCAACTTCCGACTCCCAGGTTC 1201 AAGCGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGACTACAGAAGTGCACCACCACACCCGGTTAATTTTTGTATTTT 1281 TAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGATCTCAAACTCCTGATACACCCGCCTCGGCCTCTCAAAGCACTG 1361 GGATTACAGGTGTGAGCCACCGCGCCCGGCCCTTTTCCTGCCTCCTAAACAAGTGGCCAGGAATTCTCCTCCTGCACCGG 1441 GTCCCCAGATTGTGTGGCAAGCCCTGCAGATGGCACAGGGGACTGGTTCTTCCTCGTGGAAAGCCAGGCCCGGACACCTC 1521 TCGGGCATCGCCTGTTGGGGTGACCCTCCCACACCCAGCCTGGAACCCTAGCCAGCTCAGCCTCCGTCCGCTGAGAAATC 1601 AAGGTGACCTTGTGGCTCAGCCCTCAGGGGGCACTCACCACACAAGAGTTCCCTTTCAAGACCCCCTGTTCGGGGCTGGG 1681 GCCCCCAGGAACGGTTGGGGCACCTTCCTGGGGCCCTGTTTTTCCCCAGGAGCGGGGCCTGGGAGCTGAGGGCGTCTCAT 1761 CTCCCCACAGGCATCTGCTGCTGCTCCTGGCTGCCACTCACCCCTGTGAGATGCTGAGGGCAGGATACCTGTCTGTGCGG 1841 GGCGTGGGAAAAAGGGAGAAAGCCTGGCAGAGGGTTGGGGGCTAAGAAGCAAAGGGCGTGGAAGGGCCACCGTGCACTTT 1921 TGAAGTCTCTACTTGCCAGTGGCCACCCCACCTCTCCCTGCCCTCATCCAAGGACGGACAGGCCTGGCAGGTGGACCGGA 2001 GCTGTGGGGCAGAAGCATCCCAGGCCTGGCCTCAGAGGAGGGAGGCCATGGTGAAAGTGGAGGCTGTCTGCATCCACCTC 2081 CCCAGCCTTTGTCACCGGGACCTCAGCCTGACCCCAGGCCCACCCCAGGCTGCTCACCGAGGTGGGTACCCTGCCCACCG 2161 CCAGCTCAGATGCGGTGTGTGGACTCCCTTCTCTCTGGGGGTGAGCGGGAGTTCCCTCCCCTCCACATCAGGAGCTGGGG 2241 GAGAGCTGGAGGGCCCTGGGATCCCCTTGACCCTGGTCATCAGCCCCAGCCCTGACAGGCCCTGCGTGTGCCATGTGTGG 2321 CCTGGGTTTGGAGCTCAGCACCCTGCGGGAATTCTATTAAATCTCCGATTTTATCTGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084074. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep1_SantaCruzAb
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084082. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SigmaAb
HITS-CLIP data was present in GSM1084083. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SigmaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084074 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep1_SantaCruzAb |
Location of target site | ENST00000332900.1 | 3UTR | AGAAGCGUCUGCCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000332900.1 | 3UTR | AGAAGCGUCUGCCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000332900.1 | 3UTR | AGAAGCGUCUGCCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1084082 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_SigmaAb |
Location of target site | ENST00000332900.1 | 3UTR | AGAAGCGUCUGCCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1084083 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SigmaAb |
Location of target site | ENST00000332900.1 | 3UTR | AGAAGCGUCUGCCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
138 hsa-miR-412-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT005780 | ACVR1C | activin A receptor type 1C | ![]() |
1 | 1 | |||||||
MIRT062013 | YOD1 | YOD1 deubiquitinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT345112 | ATXN7L3 | ataxin 7 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT383735 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT396956 | CELF1 | CUGBP Elav-like family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT439280 | XIAP | X-linked inhibitor of apoptosis | ![]() |
1 | 1 | |||||||
MIRT439313 | VAT1 | vesicle amine transport 1 | ![]() |
1 | 1 | |||||||
MIRT439375 | TUBA1A | tubulin alpha 1a | ![]() |
1 | 1 | |||||||
MIRT439418 | TMOD1 | tropomodulin 1 | ![]() |
1 | 1 | |||||||
MIRT439503 | SURF4 | surfeit 4 | ![]() |
1 | 1 | |||||||
MIRT439563 | SON | SON DNA binding protein | ![]() |
1 | 1 | |||||||
MIRT439598 | SLC3A2 | solute carrier family 3 member 2 | ![]() |
1 | 1 | |||||||
MIRT439670 | SETD1B | SET domain containing 1B | ![]() |
1 | 1 | |||||||
MIRT439767 | RMND5A | required for meiotic nuclear division 5 homolog A | ![]() |
1 | 1 | |||||||
MIRT439922 | PPL | periplakin | ![]() |
1 | 1 | |||||||
MIRT439947 | PLEKHA6 | pleckstrin homology domain containing A6 | ![]() |
1 | 1 | |||||||
MIRT439952 | PLCB4 | phospholipase C beta 4 | ![]() |
1 | 1 | |||||||
MIRT439961 | PKD1 | polycystin 1, transient receptor potential channel interacting | ![]() |
1 | 1 | |||||||
MIRT440005 | PEG3 | paternally expressed 3 | ![]() |
1 | 1 | |||||||
MIRT440061 | OSBPL8 | oxysterol binding protein like 8 | ![]() |
1 | 1 | |||||||
MIRT440166 | MYH14 | myosin heavy chain 14 | ![]() |
1 | 1 | |||||||
MIRT440276 | MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | ![]() |
1 | 1 | |||||||
MIRT440437 | IPO13 | importin 13 | ![]() |
1 | 1 | |||||||
MIRT440441 | INTS3 | integrator complex subunit 3 | ![]() |
1 | 1 | |||||||
MIRT440448 | INS | insulin | ![]() |
1 | 1 | |||||||
MIRT440461 | IGF2R | insulin like growth factor 2 receptor | ![]() |
1 | 1 | |||||||
MIRT440472 | IARS | isoleucyl-tRNA synthetase | ![]() |
1 | 1 | |||||||
MIRT440530 | GUCY1A3 | guanylate cyclase 1 soluble subunit alpha | ![]() |
1 | 1 | |||||||
MIRT440542 | GOLGA2 | golgin A2 | ![]() |
1 | 1 | |||||||
MIRT440569 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
1 | 1 | |||||||
MIRT440608 | FTSJD2 | cap methyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT440750 | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | ![]() |
1 | 1 | |||||||
MIRT440781 | DOT1L | DOT1 like histone lysine methyltransferase | ![]() |
1 | 1 | |||||||
MIRT440804 | DNAJA4 | DnaJ heat shock protein family (Hsp40) member A4 | ![]() |
1 | 1 | |||||||
MIRT440867 | CSDE1 | cold shock domain containing E1 | ![]() |
1 | 1 | |||||||
MIRT440890 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | ![]() |
1 | 1 | |||||||
MIRT440917 | COL1A1 | collagen type I alpha 1 chain | ![]() |
1 | 1 | |||||||
MIRT440967 | CDH22 | cadherin 22 | ![]() |
1 | 1 | |||||||
MIRT440968 | CDH2 | cadherin 2 | ![]() |
1 | 1 | |||||||
MIRT441024 | CALR | calreticulin | ![]() |
1 | 1 | |||||||
MIRT441278 | ACTB | actin beta | ![]() |
1 | 1 | |||||||
MIRT448421 | TNFAIP3 | TNF alpha induced protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462833 | BCL3 | B-cell CLL/lymphoma 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465062 | TSR1 | TSR1, ribosome maturation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT476050 | GRSF1 | G-rich RNA sequence binding factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485318 | MZT1 | mitotic spindle organizing protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT493584 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT494567 | BAK1 | BCL2 antagonist/killer 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497393 | RALY | RALY heterogeneous nuclear ribonucleoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT503250 | ZNF257 | zinc finger protein 257 | ![]() |
![]() |
2 | 10 | ||||||
MIRT503656 | ZNF138 | zinc finger protein 138 | ![]() |
![]() |
2 | 10 | ||||||
MIRT505882 | RNF219 | ring finger protein 219 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507525 | DSTN | destrin, actin depolymerizing factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT510663 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT514682 | ZNF701 | zinc finger protein 701 | ![]() |
![]() |
2 | 4 | ||||||
MIRT515370 | ZNF208 | zinc finger protein 208 | ![]() |
![]() |
2 | 6 | ||||||
MIRT525237 | KCNJ12 | potassium voltage-gated channel subfamily J member 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527963 | MTAP | methylthioadenosine phosphorylase | ![]() |
![]() |
2 | 2 | ||||||
MIRT528482 | STAMBPL1 | STAM binding protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529909 | C1orf64 | steroid receptor associated and regulated protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT531558 | SRD5A1 | steroid 5 alpha-reductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532234 | KLF2 | Kruppel like factor 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT532480 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535544 | P2RY2 | purinergic receptor P2Y2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547311 | NR1D2 | nuclear receptor subfamily 1 group D member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551795 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554939 | RAP1A | RAP1A, member of RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT558171 | EIF5A2 | eukaryotic translation initiation factor 5A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568771 | LY6K | lymphocyte antigen 6 family member K | ![]() |
![]() |
2 | 2 | ||||||
MIRT570766 | ZNF99 | zinc finger protein 99 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572405 | MRPS14 | mitochondrial ribosomal protein S14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573396 | DLC1 | DLC1 Rho GTPase activating protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT610403 | RXRB | retinoid X receptor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT610886 | SCN8A | sodium voltage-gated channel alpha subunit 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611197 | TMEM105 | transmembrane protein 105 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611244 | ZNF550 | zinc finger protein 550 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615669 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT617974 | DOCK4 | dedicator of cytokinesis 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619150 | ZNF326 | zinc finger protein 326 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619608 | MKKS | McKusick-Kaufman syndrome | ![]() |
![]() |
2 | 2 | ||||||
MIRT621053 | DGKD | diacylglycerol kinase delta | ![]() |
![]() |
2 | 2 | ||||||
MIRT623665 | HRK | harakiri, BCL2 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT624883 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT624939 | MARCH2 | membrane associated ring-CH-type finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634198 | TMOD2 | tropomodulin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT636727 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT637741 | POLR3K | RNA polymerase III subunit K | ![]() |
![]() |
2 | 2 | ||||||
MIRT638002 | ZC3H13 | zinc finger CCCH-type containing 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640395 | ZNF785 | zinc finger protein 785 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640505 | ANTXR1 | anthrax toxin receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641293 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641863 | STOML1 | stomatin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642600 | C14orf180 | chromosome 14 open reading frame 180 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642895 | CASP1 | caspase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643967 | FHL2 | four and a half LIM domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT645237 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646621 | CENPL | centromere protein L | ![]() |
![]() |
2 | 2 | ||||||
MIRT648620 | CYB561A3 | cytochrome b561 family member A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648908 | ZNF551 | zinc finger protein 551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649439 | HIBADH | 3-hydroxyisobutyrate dehydrogenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT650637 | LTF | lactotransferrin | ![]() |
![]() |
2 | 2 | ||||||
MIRT650971 | STARD3NL | STARD3 N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT651067 | ZNF518B | zinc finger protein 518B | ![]() |
![]() |
2 | 4 | ||||||
MIRT652384 | TMEM55A | phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653958 | SEPN1 | selenoprotein N | ![]() |
![]() |
2 | 2 | ||||||
MIRT656885 | KIF1C | kinesin family member 1C | ![]() |
![]() |
2 | 2 | ||||||
MIRT657965 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658080 | FOXR2 | forkhead box R2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662570 | IL2RA | interleukin 2 receptor subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT663089 | METTL10 | EEF1A lysine methyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683705 | ZNF195 | zinc finger protein 195 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683835 | ZNF682 | zinc finger protein 682 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706811 | APOL4 | apolipoprotein L4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707575 | DYNC2LI1 | dynein cytoplasmic 2 light intermediate chain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708606 | ZNF260 | zinc finger protein 260 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708859 | TMSB4X | thymosin beta 4, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT709861 | PDIK1L | PDLIM1 interacting kinase 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT709987 | RBM41 | RNA binding motif protein 41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710098 | KPNA5 | karyopherin subunit alpha 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710211 | ENAH | ENAH, actin regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT710868 | B3GALNT1 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT710986 | SUSD5 | sushi domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711460 | RNF145 | ring finger protein 145 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712302 | PGM2L1 | phosphoglucomutase 2 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713609 | SYTL4 | synaptotagmin like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713789 | MAK16 | MAK16 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT715480 | MYO9B | myosin IXB | ![]() |
![]() |
2 | 2 | ||||||
MIRT716328 | POU5F1 | POU class 5 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717252 | TMEM246 | transmembrane protein 246 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718077 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718463 | EED | embryonic ectoderm development | ![]() |
![]() |
2 | 2 | ||||||
MIRT718645 | NKPD1 | NTPase KAP family P-loop domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718982 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | ![]() |
![]() |
2 | 2 | ||||||
MIRT721078 | RPS9 | ribosomal protein S9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721419 | SEC24A | SEC24 homolog A, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT721863 | CENPJ | centromere protein J | ![]() |
![]() |
2 | 2 | ||||||
MIRT722492 | PNKD | paroxysmal nonkinesigenic dyskinesia | ![]() |
![]() |
2 | 2 | ||||||
MIRT723391 | CALN1 | calneuron 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|